Abstract
In 1994, the Ministry of Health and Welfare of Japan approved photodynamic therapy (PDT) for the treatment of early stage lung cancer (T0 and T1), superficial oesophageal cancer, superficial early stage gastric cancer and carcinoma in situ and/or dysplasia of the cervix. The decision to do so was based on studies carried out by the PDT Research Group of the Ministry, including PDT treatment of 168 early stage central lung cancers (123 superficial lesions and 45 nodular lesions) and 32 superficial oesophageal cancers. The results presented in this article were analysed according to the extent of the lesion. Of the 123 superficial lung cancers, complete remission (CR) was obtained in 93% of 89 lesions less than 1.0 cm in diameter. Larger lesions responded less well. Complete remission was obtained in 97% of the 33 superficial oesophageal cancers, although three of six patients with lesions over 3.0 cm in diameter later died of metastatic disease. The authors believe PDT to be a suitable and effective treatment for early stage lung and oesophageal cancers.
Similar content being viewed by others
References
Dougherty TJ, Laurence G, Boyle DG et al. A photoradiation in the treatment of recurrent breast cancer.J Natl Cancer Inst 1979,63:231–7
Hayata Y, Kato H, Konaka C et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer.Chest 1982,81:269–77
Hayata Y, Kato H, Konaka C et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer.Chest 1984,86:169–77
Hayata Y, Kato H, Konaka C et al. Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastro-intestinal tract.Semin Surg Oncol 1985,1:1–11
Okunaka T, Kato H, Konaka C et al. Photodynamic therapy for multiple primary bronchogenic carcinoma.Cancer 1991,68:253–8
Hayata Y, Kato H, Konaka C et al. Photodynamic therapy (PDT) in early stage lung cancer.Lung Cancer 1993,9:287–94
Edell EC, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma. A 5-year experience.Mayo Cli Proc 1987,62:8–14
Lam S, Kostashuk EC, Coy EP et al. A randomized comparative study of the safety and efficacy of photodynamic therapy using Photofrin II combined with palliative radiotherapy versus palliative radiotherapy alone in patients with inoperable obstructive non-small bronchogenic carcinoma.Photochem Photobiol 1987,46:893–8
Spinelli P, Dal Fante M, Mancini A et al. Palliation of esophageal cancer: Endoscopic Laser therapy.Dis Esoph 1996,9:98–104
McCaughan JS, Williams TE, Bethel BH. Palliative of esophageal malignancy with photodynamic therapy.Ann Thorac Surg 1985,40:150–3
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayata, Y., Kato, H., Furuse, K. et al. Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a japanese multi-centre study. Laser Med Sci 11, 255–259 (1996). https://doi.org/10.1007/BF02134916
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02134916